Xue-Li Bai (Xueli Bai)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 42

Top Topics

Top Venues

Cell death and differentiation

Hepatology communications

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaozhen Zhang, Mengyi Lao, Hanshen Yang, Kang Sun, Yunfei Dong, Lihong He, Xinchi Jiang, Honghui Wu, Yangwei Jiang, Muchun Li, Honggang Ying, Xinyuan Liu, Jian Xu, Yan Chen, Hanjia Zhang, Ruhong Zhou, Jianqing Gao, Xue-Li Bai, Jianpeng Sheng
Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Autophagy (2024)
Ailian Wang, Chen Chen, Chen Mei, Shengduo Liu, Cong Xiang, Wen Fang, Fei Zhang, Yifan Xu, Shasha Chen, Qi Zhang, Xue-Li Bai, Aifu Lin, Dante Neculai, Bing Xia, Cunqi Ye, Jian Zou, Jianpeng Sheng, Xin-Hua Feng, Xinran Li, Chengyong Shen, Ping-Long Xu
Innate immune sensing of lysosomal dysfunction drives multiple lysosomal storage disorders. Nature cell biology 26 (2) (2024)
Sicong Huang, Jiaqi Yang, Teng Xie, Yangwei Jiang, Yifan Hong, Xinyuan Liu, Xuyan He, Damiano Buratto, Dong Zhang, Ruhong Zhou, Tingbo Liang, Xue-Li Bai
Inhibition of DEF-p65 Interactions as a Potential Avenue to Suppress Tumor Growth in Pancreatic Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (28) (2024)
Xiaozhen Zhang, Mengyi Lao, Hanshen Yang, Kang Sun, Yunfei Dong, Lihong He, Xinchi Jiang, Honghui Wu, Yangwei Jiang, Muchun Li, Honggang Ying, Xinyuan Liu, Jian Xu, Yan Chen, Hanjia Zhang, Ruhong Zhou, Jianqing Gao, Xue-Li Bai, Jianpeng Sheng
Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Autophagy 20 (6) (2024)
Ailian Wang, Chen Chen, Chen Mei, Shengduo Liu, Cong Xiang, Wen Fang, Fei Zhang, Yifan Xu, Shasha Chen, Qi Zhang, Xue-Li Bai, Aifu Lin, Dante Neculai, Bing Xia, Cunqi Ye, Jian Zou, Jianpeng Sheng, Xin-Hua Feng, Xinran Li, Chengyong Shen, Ping-Long Xu
Innate immune sensing of lysosomal dysfunction drives multiple lysosomal storage disorders. Nature cell biology (2024)
Xiaozhen Zhang, Mengyi Lao, Hanshen Yang, Kang Sun, Yunfei Dong, Lihong He, Xinchi Jiang, Honghui Wu, Yangwei Jiang, Muchun Li, Honggang Ying, Xinyuan Liu, Jian Xu, Yan Chen, Hanjia Zhang, Ruhong Zhou, Jianqing Gao, Xue-Li Bai, Jianpeng Sheng
Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Autophagy 20 (6) (2024)
Sicong Huang, Jiaqi Yang, Teng Xie, Yangwei Jiang, Yifan Hong, Xinyuan Liu, Xuyan He, Damiano Buratto, Dong Zhang, Ruhong Zhou, Tingbo Liang, Xue-Li Bai
Inhibition of DEF-p65 Interactions as a Potential Avenue to Suppress Tumor Growth in Pancreatic Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (28) (2024)
Sicong Huang, Jiaqi Yang, Teng Xie, Yangwei Jiang, Yifan Hong, Xinyuan Liu, Xuyan He, Damiano Buratto, Dong Zhang, Ruhong Zhou, Tingbo Liang, Xue-Li Bai
Inhibition of DEF-p65 Interactions as a Potential Avenue to Suppress Tumor Growth in Pancreatic Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (28) (2024)
Xiaozhen Zhang, Mengyi Lao, Hanshen Yang, Kang Sun, Yunfei Dong, Lihong He, Xinchi Jiang, Honghui Wu, Yangwei Jiang, Muchun Li, Honggang Ying, Xinyuan Liu, Jian Xu, Yan Chen, Hanjia Zhang, Ruhong Zhou, Jianqing Gao, Xue-Li Bai, Jianpeng Sheng
Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Autophagy 20 (6) (2024)
Sicong Huang, Jiaqi Yang, Teng Xie, Yangwei Jiang, Yifan Hong, Xinyuan Liu, Xuyan He, Damiano Buratto, Dong Zhang, Ruhong Zhou, Tingbo Liang, Xue-Li Bai
Inhibition of DEF-p65 Interactions as a Potential Avenue to Suppress Tumor Growth in Pancreatic Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Xiaozhen Zhang, Mengyi Lao, Hanshen Yang, Kang Sun, Yunfei Dong, Lihong He, Xinchi Jiang, Honghui Wu, Yangwei Jiang, Muchun Li, Honggang Ying, Xinyuan Liu, Jian Xu, Yan Chen, Hanjia Zhang, Ruhong Zhou, Jianqing Gao, Xue-Li Bai, Jianpeng Sheng
Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Autophagy (2024)
Ailian Wang, Chen Chen, Chen Mei, Shengduo Liu, Cong Xiang, Wen Fang, Fei Zhang, Yifan Xu, Shasha Chen, Qi Zhang, Xue-Li Bai, Aifu Lin, Dante Neculai, Bing Xia, Cunqi Ye, Jian Zou, Jianpeng Sheng, Xin-Hua Feng, Xinran Li, Chengyong Shen, Ping-Long Xu
Innate immune sensing of lysosomal dysfunction drives multiple lysosomal storage disorders. Nature cell biology 26 (2) (2024)
Ailian Wang, Chen Chen, Chen Mei, Shengduo Liu, Cong Xiang, Wen Fang, Fei Zhang, Yifan Xu, Shasha Chen, Qi Zhang, Xue-Li Bai, Aifu Lin, Dante Neculai, Bing Xia, Cunqi Ye, Jian Zou, Jianpeng Sheng, Xin-Hua Feng, Xinran Li, Chengyong Shen, Ping-Long Xu
Innate immune sensing of lysosomal dysfunction drives multiple lysosomal storage disorders. Nature cell biology 26 (2) (2024)
Chengxiang Guo, Junlei Zhang, Xin Huang, Yiwen Chen, Jianpeng Sheng, Xing Huang, Jun-Hui Sun, Wen-Bo Xiao, Ke Sun, Shunliang Gao, Risheng Que, Yan Shen, Min Zhang, Jian Wu, Xue-Li Bai, Jianpeng Sheng
Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trial. Hepatology communications 7 (3) (2023)
Li-Hong He, Xiao-Zhen Zhang, Meng-Yi Lao, Han-Jia Zhang, Han-Shen Yang, Xue-Li Bai
Immune Checkpoint Neuropilins as Novel Biomarkers and Therapeutic Targets for Pancreatic Cancer. Cancers 15 (8) (2023)
Li-Hong He, Xiao-Zhen Zhang, Meng-Yi Lao, Han-Jia Zhang, Han-Shen Yang, Xue-Li Bai
Immune Checkpoint Neuropilins as Novel Biomarkers and Therapeutic Targets for Pancreatic Cancer. Cancers 15 (8) (2023)
Chengxiang Guo, Junlei Zhang, Xin Huang, Yiwen Chen, Jianpeng Sheng, Xing Huang, Jun-Hui Sun, Wen-Bo Xiao, Ke Sun, Shunliang Gao, Risheng Que, Yan Shen, Min Zhang, Jian Wu, Xue-Li Bai, Jianpeng Sheng
Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trial. Hepatology communications 7 (3) (2023)
Jianghui Tang, Jianpeng Sheng, Qi Zhang, Yongtao Ji, Xun Wang, Junlei Zhang, Jiangchao Wu, Jinyuan Song, Xue-Li Bai, Tingbo Liang
Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability. Journal for immunotherapy of cancer 11 (2) (2023)
Chengxiang Guo, Junlei Zhang, Xin Huang, Yiwen Chen, Jianpeng Sheng, Xing Huang, Jun-Hui Sun, Wen-Bo Xiao, Ke Sun, Shunliang Gao, Risheng Que, Yan Shen, Min Zhang, Jian Wu, Xue-Li Bai, Jianpeng Sheng
Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trial. Hepatology communications 7 (3) (2023)
Chengxiang Guo, Junlei Zhang, Xin Huang, Yiwen Chen, Jianpeng Sheng, Xing Huang, Jun-Hui Sun, Wen-Bo Xiao, Ke Sun, Shunliang Gao, Risheng Que, Yan Shen, Min Zhang, Jian Wu, Xue-Li Bai, Jianpeng Sheng
Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trial. Hepatology communications 7 (3) (2023)
Chengxiang Guo, Junlei Zhang, Xin Huang, Yiwen Chen, Jianpeng Sheng, Xing Huang, Jun-Hui Sun, Wen-Bo Xiao, Ke Sun, Shunliang Gao, Risheng Que, Yan Shen, Min Zhang, Jian Wu, Xue-Li Bai, Jianpeng Sheng
Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trial. Hepatology communications 7 (3) (2023)
Jianghui Tang, Jianpeng Sheng, Qi Zhang, Yongtao Ji, Xun Wang, Junlei Zhang, Jiangchao Wu, Jinyuan Song, Xue-Li Bai, Tingbo Liang
Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability. Journal for immunotherapy of cancer 11 (2) (2023)
Yi Duan, Xiaozhen Zhang, Honggang Ying, Jian Xu, Hanshen Yang, Kang Sun, Lihong He, Muchun Li, Yongtao Ji, Tingbo Liang, Xue-Li Bai
Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix. Oncogene (2023)
Jianghui Tang, Jianpeng Sheng, Qi Zhang, Yongtao Ji, Xun Wang, Junlei Zhang, Jiangchao Wu, Jinyuan Song, Xue-Li Bai, Tingbo Liang
Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability. Journal for immunotherapy of cancer 11 (2) (2023)
Qi Zhang, Ye Mao, Cheng Lin, Manyi Hu, Yangyang Wang, Yu Lou, Quanming Kong, Jungang Zhang, Junjian Li, Yuhua Zhang, Tianxin Yang, Xu Sun, Weiyun Yao, Yongfei Hua, Haifeng Huang, Minghui Xu, Xiaoguang Wang, Xin Yu, Weifeng Tao, Runtian Liu, Yuming Gao, Tian Wang, Jianing Wang, Xiaobao Wei, Jiangchao Wu, Zhengping Yu, Chengwu Zhang, Chaohui Yu, Xue-Li Bai, Tingbo Liang
Mass cytometry-based peripheral blood analysis as a novel tool for early detection of solid tumours: a multicentre study. Gut (2022)
Hanshen Yang, Xiaozhen Zhang, Mengyi Lao, Kang Sun, Lihong He, Jian Xu, Yi Duan, Yan Chen, Honggang Ying, Muchun Li, Chengxiang Guo, Qingsong Lu, Sicheng Wang, Wei Su, Jianpeng Sheng, Xue-Li Bai
Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer. Cell death and differentiation 30 (2) (2022)
Lingyue Liu, Xing Huang, Fukang Shi, Jinyuan Song, Chengxiang Guo, Jiaqi Yang, Tingbo Liang, Xue-Li Bai
Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Hanshen Yang, Xiaozhen Zhang, Mengyi Lao, Kang Sun, Lihong He, Jian Xu, Yi Duan, Yan Chen, Honggang Ying, Muchun Li, Chengxiang Guo, Qingsong Lu, Sicheng Wang, Wei Su, Jianpeng Sheng, Xue-Li Bai
Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer. Cell death and differentiation 30 (2) (2022)
Hanshen Yang, Xiaozhen Zhang, Mengyi Lao, Kang Sun, Lihong He, Jian Xu, Yi Duan, Yan Chen, Honggang Ying, Muchun Li, Chengxiang Guo, Qingsong Lu, Sicheng Wang, Wei Su, Jianpeng Sheng, Xue-Li Bai
Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer. Cell death and differentiation 30 (2) (2022)
Hanshen Yang, Xiaozhen Zhang, Mengyi Lao, Kang Sun, Lihong He, Jian Xu, Yi Duan, Yan Chen, Honggang Ying, Muchun Li, Chengxiang Guo, Qingsong Lu, Sicheng Wang, Wei Su, Jianpeng Sheng, Xue-Li Bai
Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer. Cell death and differentiation (2022)
Qingsong Lu, Xiaozhen Zhang, Tingbo Liang, Xue-Li Bai
O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy. Molecular medicine (Cambridge, Mass.) 28 (1) (2022)
Yong Ding, Shijian Ruan, Yubizhuo Wang, Jiayuan Shao, Rui Sun, Wuwei Tian, Nan Xiang, Weigang Ge, Xiuming Zhang, Kunkai Su, Jingwen Xia, Qiang Huang, Weihai Liu, Qinxue Sun, Haibo Dong, Mylène C Q Farias, Tiannan Guo, Andrey S Krylov, Wenjie Liang, Wenbo Xiao, Xue-Li Bai, Tingbo Liang
Novel deep learning radiomics model for preoperative evaluation of hepatocellular carcinoma differentiation based on computed tomography data. Clinical and translational medicine 11 (11) (2022)
Hanshen Yang, Xiaozhen Zhang, Mengyi Lao, Kang Sun, Lihong He, Jian Xu, Yi Duan, Yan Chen, Honggang Ying, Muchun Li, Chengxiang Guo, Qingsong Lu, Sicheng Wang, Wei Su, Jianpeng Sheng, Xue-Li Bai
Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer. Cell death and differentiation 30 (2) (2022)
Xiaozhen Zhang, Mengyi Lao, Jian Xu, Yi Duan, Hanshen Yang, Muchun Li, Honggang Ying, Lihong He, Kang Sun, Chengxiang Guo, Wen Chen, Haitao Jiang, Xiaoyu Zhang, Xue-Li Bai, Tingbo Liang
Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors. Journal for immunotherapy of cancer 10 (3) (2022)
Hanshen Yang, Xiaozhen Zhang, Mengyi Lao, Kang Sun, Lihong He, Jian Xu, Yi Duan, Yan Chen, Honggang Ying, Muchun Li, Chengxiang Guo, Qingsong Lu, Sicheng Wang, Wei Su, Jianpeng Sheng, Xue-Li Bai
Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer. Cell death and differentiation 30 (2) (2022)
Mengyi Lao, Xiaozhen Zhang, Hanshen Yang, Xue-Li Bai, Tingbo Liang
RCAN1-mediated calcineurin inhibition as a target for cancer therapy. Molecular medicine (Cambridge, Mass.) 28 (1) (2022)
Mei Tang, Yang Zhao, Jianhui Zhao, Shumei Wei, Mingwei Liu, Nairen Zheng, Didi Geng, Shixun Han, Yuchao Zhang, Guoxuan Zhong, Shuaifeng Li, Xiuming Zhang, Chenliang Wang, Huan Yan, Xiaolei Cao, Li Li, Xue-Li Bai, Junfang Ji, Xin-Hua Feng, Jun Qin, Jianpeng Sheng, Jonathan C Zhao
Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes. Science advances 8 (25) (2022)
Jianpeng Sheng, Junlei Zhang, Lin Wang, Vincent Tano, Jianghui Tang, Xun Wang, Jiangchao Wu, Jinyuan Song, Yaxing Zhao, Jingxia Rong, Fei Cheng, Jianfeng Wang, Yinan Shen, Liang Wen, Junjun He, Hui Zhang, Taohong Li, Qi Zhang, Xue-Li Bai, Zhimin Lu, Tingbo Liang
Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny. Gut (2021)
Xiaozhen Zhang, Xing Huang, Jian Xu, Enliang Li, Mengyi Lao, Tianyu Tang, Gang Zhang, Chengxiang Guo, Xiaoyu Zhang, Wen Chen, Dipesh Kumar Yadav, Xue-Li Bai, Tingbo Liang
NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1. Nature communications 12 (1) (2021)
Mengyi Lao, Xiaozhen Zhang, Tao Ma, Jian Xu, Hanshen Yang, Yi Duan, Honggang Ying, Xiaoyu Zhang, Chengxiang Guo, Junyu Qiu, Xue-Li Bai, Jianpeng Sheng
Regulator of calcineurin 1 gene isoform 4 in pancreatic ductal adenocarcinoma regulates the progression of tumor cells. Oncogene 40 (17) (2021)
Dipesh Kumar Yadav, Akanand Singh, Qi Zhang, Xue-Li Bai, Wei Zhang, Rajesh Kumar Yadav, Alina Singh, Li Zhiwei, Vishnu Prasad Adhikari, Jianpeng Sheng
Involvement of liver in COVID-19: systematic review and meta-analysis. Gut 70 (4) (2020)
Qi Zhang, Yu Lou, Jiaqi Yang, Junli Wang, Jie Feng, Yali Zhao, Lin Wang, Xing Huang, Qihan Fu, Mao Ye, Xiaozhen Zhang, Yiwen Chen, Ce Ma, Hongbin Ge, Jianing Wang, Jiangchao Wu, Tao Wei, Qi Chen, Junqing Wu, Chengxuan Yu, Yanyu Xiao, Xinhua Feng, Guoji Guo, Tingbo Liang, Xue-Li Bai
Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas. Gut 68 (11) (2019)